Impact of asymptomatic hypertension on left ventricular functions

Janardan V Bhatt1

  • 1Department of Physiology, Smt. NHL Municipal Medical College, V.S. Hospital Campus Ellisbridge, Ahmedabad. jvbhattin@yahoo.com

Insights

Asymptomatic hypertension impairs left ventricular (LV) contractile function, indicated by reduced fractional fiber shortening (FFS). Managing hypertension by reducing afterload is crucial for improving LV contractile state in these patients.

Area of Science:

  • Cardiology
  • Hypertension Research
  • Echocardiography

Background:

  • Asymptomatic hypertension can lead to structural and functional changes in the left ventricle (LV).
  • Understanding the determinants of LV systolic function in hypertensive individuals is critical for early intervention.

Purpose of the Study:

  • To compare LV systolic functions and their determinants in subjects with asymptomatic hypertension versus normotensive subjects.
  • To investigate the impact of hypertension on LV geometry and contractile state.

Main Methods:

  • M-mode echocardiography was utilized to assess LV systolic function parameters.
  • Sixty healthy subjects and sixty hypertensive subjects were included in the comparative study.
  • Techholz's formula was applied to calculate stroke volume, ejection fraction, cardiac output, and cardiac index.

Main Results:

  • Hypertensive subjects exhibited significantly higher resting stroke volume, cardiac output, and cardiac index compared to normotensive subjects (P<0.05).
  • Fractional fiber shortening (FFS) and other LV contractile state parameters were significantly reduced in hypertensive individuals (P<0.05).
  • Impaired FFS was linked to alterations in LV wall thickness, cavity dimensions, geometry, and myocardial fibrous changes.

Conclusions:

  • Asymptomatic hypertension is associated with impaired LV contractile state, even with normal systolic function, due to altered LV geometry.
  • Reducing LV afterload is a primary management goal to improve LV contractile state in hypertensive patients.
  • Further research is needed to understand the prognostic implications and optimize management strategies.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...